Surgical Robot Platform Company KouTech Nets Over USD 10 Mn in Series A+ Round
KouTech (Chinese: 昂泰微精), an ultra-microscopic and high-precision surgical robot platform company founded in 2022, announced that it had raised a USD tens of million Series A+ round of financing only three months after its completion of Series A. This financing round was led by Temasek (Chinese: 淡马锡). Life Venture (Chinese: 生命资本) continued to act as the exclusive financial adviser. Proceeds will be used in company’s overseas registration, product R&D, and team expansion.
Briefing Yesterday 11:20 AM
· Healthcare
YingHe Neuro Raises Over CNY 100 Mn in Angel Round
Briefing Jan 17, 2023 10:36 AM
· Healthcare
Medical Equipment Company PowerSite Nets Over CNY 100 Mn in Series B
In-depth
Healthcare
China VC Investment List Q4 2022 – Healthcare
For healthcare, we at EqualOcean have identified 20 companies worth watching in Q4 identified by proceedings. We select venture capital investments of over CNY 200 million on average or the equivalent value in USD in a single round.
Jan 05, 2023 06:55 PM
Briefing Jan 13, 2023 11:03 AM
· Healthcare
Equipment Company Keyto Nets Over CNY 100 Mn in Series C
Briefing Jan 12, 2023 10:53 AM
· Healthcare
IVD Company Bioantibody Nets Over CNY 100 Mn in Series A
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 22, 2021 03:11 PM
Briefing Sep 09, 2022 04:12 PM
· Healthcare
Trulive Nets Hundreds of Mns of CNY in pre-Series B Financing Round
Briefing Sep 05, 2022 04:50 PM
· Healthcare
LinkZill Nets Tens of Millions of CNY in pre-Series A+
Briefing Jun 24, 2022 11:15 AM
· Healthcare
F-star to be acquired by China biopharmaceutical with USD 161million
Briefing Jun 24, 2022 11:07 AM
· Healthcare
"Delisting warning" of Whitson pharmaceuticals on the New York Stock Exchange
Insight
Briefing Jun 24, 2022 10:46 AM
· Healthcare
East China medicine "liraglutide" goes to sea
Briefing Jun 23, 2022 06:25 PM
· Healthcare
Nearly half of the equity of two subsidiaries of Tongrentang was transferred to Tongrentang medical care
Insight
Healthcare
Opportunities and Challenges Hidden in the CGT Industry in China
CGT (Cell and Gene Therapy) is a sector with high growth potential. CAR-T, as one of the main CGT currently, presents great value for both doctors and patients. This article showcases the industry pain points and opportunities faced in the CAR-T sub-sector.
Jan 17, 2023 05:48 PM
Briefing Jun 23, 2022 06:24 PM
· Healthcare
Baiyunshan: suspension of the spin off of Guangzhou Pharmaceutical for overseas listing
Briefing Jun 23, 2022 10:36 AM
· Healthcare
Germany Merck "cetuximab" new indications for head and neck squamous cell carcinoma approved in China
Briefing Jun 23, 2022 10:27 AM
· Healthcare
Yanye new crown drug 3CL protein inhibitor has been suspended approval
Briefing Jun 23, 2022 10:24 AM
· Healthcare
Sanofi Greater China will be headed by Shi Wang, and Henting he will become the global head of the digital business unit
See more
Read next
Insight
In-depth
Insight
In-depth